Therapeutic effects of alteplase intravenous thrombolysis on different types of acute cerebral infarction: a controlled randomized analysis.
Am J Transl Res
; 13(8): 9129-9135, 2021.
Article
in En
| MEDLINE
| ID: mdl-34540027
ABSTRACT
OBJECTIVE:
To test the effects of alteplase (PA) intravenous thrombolysis on different types of acute cerebral infarction (ACI).METHODS:
One hundred and ten patients with the ACI admitted from April 2018 to April 2019 were selected and randomly assigned to a research group and a reference group equally. The two groups received conventional treatment with a subcutaneous injection of low molecular weight heparin calcium of 5000 IU, and the research group received additional PA intravenous thrombolysis treatment. The therapeutic effects of the two groups were compared.RESULTS:
There were no significant differences in terms of general information and National Institutes of Health Stroke Scale (NIHSS) score at T0 (P>0.05) between the two groups; the research group garnered better results in the NIHSS scores at T1, T2, T3, and T4 than the reference group (P<0.001); a decrease was found in the Modified Rankin Scale (MRS) after treatment (P<0.001), with lower scores in the research group (P<0.001); the research group obtained a higher total effective rate than the reference group (P<0.05). Remarkably higher Barthel scores of the two groups after treatment were found (P<0.001), with higher scores collected from the research group (P<0.001); patients in the research group enjoyed a lower incidence of bleeding events than the reference group (P<0.05). The levels of Interleukin-1ß (IL-1ß), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), superoxide dismutase (SOD), glutathione peroxidase (GSH-px), and malondialdehyde (MDA) were apparently optimized after treatment, with superior results observed in the research group (P<0.05).CONCLUSION:
PA intravenous thrombolysis effectively improves the neurological function of patients with different types of ACI and their quality of life, and reduces bleeding events, which is worthy of promotion.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Aspects:
Patient_preference
Language:
En
Journal:
Am J Transl Res
Year:
2021
Document type:
Article
Affiliation country: